Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunder Biomedical Tech CoROCO:4115 +3.60%51 3-Year ROIIC % is 31.54 as of Dec. 2025, which is 2% below its 10-year median of 32.07. GuruFocus rates ROCO:4115 with a GF Score™ of 51/100 and a GF Value™ of NT$10.65 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Sunder Biomedical Tech Co ranks better than 77.46% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Sunder Biomedical Tech Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 31.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Sunder Biomedical Tech Co's 3-Year ROIIC % or its related term are showing as below:
ROCO:4115's 3-Year ROIIC % is ranked better than 77.46% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.52
vs ROCO:4115: 31.54
Sunder Biomedical Tech Co (ROCO:4115) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Sunder Biomedical Tech Co 3-Year ROIIC % Related Terms
Sunder Biomedical Tech Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4115 vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Sunder Biomedical Tech Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunder Biomedical Tech Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sunder Biomedical Tech Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Sunder Biomedical Tech Co's 3-Year ROIIC % falls into.
Sunder Biomedical Tech Co 3-Year ROIIC % Calculation
Sunder Biomedical Tech Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -10.9626812 (Dec. 2025) - 15.529 (Dec. 2022) )
/
( 1038.655 (Dec. 2025) - 1122.654 (Dec. 2022) )
=
-26.4916812
/
-83.999
=
31.54%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Sunder Biomedical Tech Co (ROCO:4115) has a 3-Year ROIIC % of 31.54 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sunder Biomedical Tech Co and its competitors. This is near median its historical median of 32.07. Over the past decade, Sunder Biomedical Tech Co's 3-Year ROIIC % has ranged from 10.32 to 67.15. According to the industry distribution chart, Sunder Biomedical Tech Co ranks #179 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 22.5%.
Is Sunder Biomedical Tech Co's 3-Year ROIIC % too high?
Sunder Biomedical Tech Co's current 3-Year ROIIC % of 31.54 is near median its 10-year median of 32.07. Over the past 10 years, this metric has ranged from a low of 10.32 to a high of 67.15. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.52. Sunder Biomedical Tech Co's value of 31.54 is 1975% above this industry median. Based on the distribution chart, Sunder Biomedical Tech Co ranks #179 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sunder Biomedical Tech Co has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sunder Biomedical Tech Co's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sunder Biomedical Tech Co ranks #179 out of 794 companies for 3-Year ROIIC %. This places Sunder Biomedical Tech Co in the top 23% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.52. Sunder Biomedical Tech Co's value of 31.54 is 1975% above this benchmark. Historically, Sunder Biomedical Tech Co's own 3-Year ROIIC % has ranged from 10.32 to 67.15 over the past decade. While the company's 10-year median is 32.07 vs. the industry median of 1.52, Sunder Biomedical Tech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.52, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunder Biomedical Tech Co's current 3-Year ROIIC % of 31.54 is 1975% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Sunder Biomedical Tech Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunder Biomedical Tech Co's current 3-Year ROIIC % is 31.54, which is near median its own 10-year median of 32.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunder Biomedical Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co (ROCO:4115) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$10.65, compared to a current price of NT$7.78 — trading 26.9% below its estimated fair value. The current 3-Year ROIIC % is 31.54, which is near median its 10-year median of 32.07 and 1975% above the Medical Devices & Instruments industry median of 1.52. Sunder Biomedical Tech Co's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Sunder Biomedical Tech Co (ROCO:4115), the current 3-Year ROIIC % is 31.54 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sunder Biomedical Tech Co (ROCO:4115) Overvalued in 2026?
Based on GuruFocus' analysis, Sunder Biomedical Tech Co stock appears to be undervalued.
The current stock price of NT$7.78 is trading 26.9% below its estimated GF Value™ of NT$10.65.
GuruFocus considers Sunder Biomedical Tech Co to be Modestly Undervalued.
Key valuation signals for ROCO:4115:
3-Year ROIIC %: 31.54 (near median its 10-year median of 32.07)
GF Value™: NT$10.65 vs. price of NT$7.78 (26.9% below fair value)
Industry Position: 1975% above the Medical Devices & Instruments median (#179 of 794)
No single metric tells the full story. See the ROCO:4115 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sunder Biomedical Tech Co Ltd is engaged in providing medical devices. Its products include Protective Goggles; Meltblown Nonwoven Fabric/Mask; Suction Irrigation Set; Smoke Filter; Endo Bag; Blood Line Set for Hemodialysis and others.
51GF Score
Get the complete analysis for ROCO:4115
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4115 has been successfully added to your 
